Widmann Financial Services Inc. Boosts Stake in CVS Health Co. (NYSE:CVS)

Widmann Financial Services Inc. increased its holdings in CVS Health Co. (NYSE:CVS) by 1.8% during the 3rd quarter, HoldingsChannel reports. The fund owned 11,506 shares of the pharmacy operator’s stock after acquiring an additional 200 shares during the quarter. Widmann Financial Services Inc.’s holdings in CVS Health were worth $724,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cetera Investment Advisers grew its position in shares of CVS Health by 190.9% during the first quarter. Cetera Investment Advisers now owns 407,844 shares of the pharmacy operator’s stock worth $32,530,000 after buying an additional 267,664 shares in the last quarter. Cetera Advisors LLC grew its holdings in CVS Health by 13.3% during the 1st quarter. Cetera Advisors LLC now owns 123,884 shares of the pharmacy operator’s stock worth $9,881,000 after acquiring an additional 14,551 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of CVS Health by 27.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 13,865 shares of the pharmacy operator’s stock valued at $1,106,000 after purchasing an additional 2,970 shares in the last quarter. Transcend Capital Advisors LLC lifted its position in shares of CVS Health by 27.1% during the second quarter. Transcend Capital Advisors LLC now owns 22,639 shares of the pharmacy operator’s stock worth $1,337,000 after purchasing an additional 4,826 shares during the last quarter. Finally, Park Place Capital Corp grew its stake in CVS Health by 18.1% in the second quarter. Park Place Capital Corp now owns 2,033 shares of the pharmacy operator’s stock worth $120,000 after purchasing an additional 311 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Mizuho decreased their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. UBS Group lifted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. TD Cowen increased their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. Truist Financial reaffirmed a “buy” rating and issued a $67.00 price target (down from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Finally, StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $70.33.

CVS Health Stock Down 0.2 %

CVS stock opened at $59.82 on Friday. The firm’s 50-day moving average is $59.36 and its two-hundred day moving average is $58.74. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $75.28 billion, a price-to-earnings ratio of 15.18, a price-to-earnings-growth ratio of 1.02 and a beta of 0.55. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the company posted $2.21 EPS. On average, analysts forecast that CVS Health Co. will post 5.37 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.45%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.